Chao Pei-Chun, Chien Wu-Chien, Chung Chi-Hsiang, Huang Chih-Kang, Li Hao-Ming, Tzeng Nian-Sheng
Department of Psychiatry, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei, Taiwan.
Department of Psychiatry, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Front Aging Neurosci. 2022 Mar 23;14:771486. doi: 10.3389/fnagi.2022.771486. eCollection 2022.
To explore the association between leptospirosis, the risk of dementia, and the potential protective role of antibiotic treatment.
We conducted a retrospective cohort nationwide, population-based study, from Taiwan's National Health Insurance Research Database (NHIRD). We enrolled 1,428 subjects aged 50 years or above, in the index year of 2000, which included those retrieved from the NHIRD record. Dementia diagnosis and incidence over 16 years follow-up was retrieved from the NHIRD records. The Fine and Gray survival analysis was used to determine the risk of dementia, and the results were presented as a sub-distribution hazard ratio (SHR) with a 95% confidence interval.
In the study period, 43 of the 357 leptospirosis patients developed dementia, as compared to 103 of the control group (930.90 vs. 732.49 per 10 person-years). By the Fine and Gray survival analysis, the leptospirosis was associated with the risk of dementia, and the adjusted SHR was 1.357 (95% confidence interval [CI]: 1.213-1.519, < 0.001), across 16-year of the follow-up period. To exclude the protopathic bias, the sensitivity analysis was conducted. This analysis revealed that the leptospirosis was associated with the increased risk of dementia, even after excluding the dementia diagnosis within the first year (adjusted SHR = 1.246, 95%CI: 1.114-1.395, < 0.001) or within the first 5 years (adjusted SHR = 1.079, 95%CI: 1.023-1.152, = 0.028), antibiotic treatment for leptospirosis was associated with the reduced risk of dementia ( = 0.001).
Leptospirosis was associated with an increased risk for dementia, and antibiotic treatment was associated with a reduced risk. Further research will be necessary to explore the underlying mechanisms of this association.
探讨钩端螺旋体病、痴呆风险以及抗生素治疗的潜在保护作用之间的关联。
我们利用台湾地区全民健康保险研究数据库(NHIRD)进行了一项全国性基于人群的回顾性队列研究。我们纳入了2000年索引年时年龄在50岁及以上的1428名受试者,这些受试者均来自NHIRD记录。从NHIRD记录中获取痴呆诊断情况及16年随访期间的发病率。采用Fine和Gray生存分析来确定痴呆风险,结果以95%置信区间的亚分布风险比(SHR)呈现。
在研究期间,357名钩端螺旋体病患者中有43人患上痴呆,而对照组103人患上痴呆(每10人年分别为930.90例和732.49例)。通过Fine和Gray生存分析,在16年的随访期内,钩端螺旋体病与痴呆风险相关,调整后的SHR为1.357(95%置信区间[CI]:1.213 - 1.519,P < 0.001)。为排除原发病偏倚,进行了敏感性分析。该分析显示,即使排除第一年(调整后的SHR = 1.246,95%CI:1.114 - 1.395,P < 0.001)或前5年(调整后的SHR = 1.079,95%CI:1.023 - 1.152,P = 0.028)内的痴呆诊断,钩端螺旋体病仍与痴呆风险增加相关,而针对钩端螺旋体病的抗生素治疗与痴呆风险降低相关(P = 0.001)。
钩端螺旋体病与痴呆风险增加相关,抗生素治疗与痴呆风险降低相关。有必要进一步研究以探索这种关联的潜在机制。